Business, energy, technology, markets and global industry news from Business News Today

laboratory-developed tests

PharmaDeviceNews laboratory-developed tests
Representative image: AI-powered blood-based lung cancer screening is gaining momentum as DELFI Diagnostics secures New York approval for FirstLook Lung, expanding nationwide access to its laboratory-developed cancer detection test.
Medical Devices & Diagnostics

Why DELFI Diagnostics’ New York approval could shake up the lung cancer screening market

DELFI Diagnostics can now offer FirstLook Lung in all 50 states. Find out what this means for blood-based cancer screening.

Read More
Representative image: A precision oncology laboratory processes blood samples for molecular profiling, reflecting Caris Life Sciences’ Caris Assure submission to New York regulators for blood-based cancer testing authorization.
Medical Devices & Diagnostics

Can Caris Life Sciences turn Caris Assure into a broader precision oncology platform?

Caris wants New York access for Caris Assure. The bigger test is whether liquid biopsy scale can satisfy tougher state oversight.

Read More
Medical Devices & Diagnostics

Plus Therapeutics reimbursement push gains traction as AMA grants CNSide a dedicated PLA code

Plus Therapeutics has won an AMA PLA code for CNSide. Read why this reimbursement milestone could shape adoption, coverage, and diagnostic growth.

Read More